The current evidence is insufficient to assess the balance of benefits and harms of screening for obstructive sleep apnea (OSA) in asymptomatic adults, according to a new U.S. Preventive Services Task Force recommendation statement, which is published in the current issue of JAMA.

In a statement based on comments submitted to the USPSTF in June, the AASM emphasized the importance of screening patients who have a high risk for OSA, even if they don’t have any sleep-related symptoms. The necessity of sleep apnea screening was described further in a JAMA editorial by AASM member Dr. Susan Redline, and in comments to MedPage Today by AASM Immediate Past President Dr. Nathaniel Watson.